AIM at Melanoma Launches The First Online Melanoma Learning Center

June 13, 2018 (Richmond, California)… AIM at Melanoma, the trusted global leader in melanoma education and advocacy, recently launched The Melanoma Learning Center (MLC), a virtual information hub to help melanoma patients, healthcare providers, caregivers, and families find reliable and current information and resources.  The first of its kind, The Melanoma Learning Center offers easy-to-access information, tools, and resources that are medically accurate, up-to-date, and presented in a way that is understandable for the non-expert. Content has been developed in partnership with leading melanoma oncology experts and includes:

  • Comprehensive and up-to-date information on all aspects of every melanoma treatment currently approved by the U.S. Food and Drug Administration
  • Downloadable informational packets, which patients are encouraged to discuss with their healthcare providers, that include lists of common side effect symptoms, suggestions on side effect management, and dosing calendars.
  • Patient support resources such as a melanoma video library; clinical trial matching service; an online directory of melanoma specialists; and a comprehensive melanoma terminology glossary.
  • Professional resources for healthcare providers to use in their practices.
  • Resources for the international patient community.

“AIM at Melanoma is dedicated to providing hope, help, support, and education to improve the lives of melanoma survivors,” shared Valerie Guild, President of AIM at Melanoma. “This is the kind of tailored education that many people touched by melanoma want and need to increase their knowledge about this cancer. The informational packets, in particular, are exciting to me because they provide extensive information on how patients can help manage the side effects of their medication. We’re proud to make this information widely available online.”

“While patients and healthcare professionals may have very different needs and levels of understanding around the same topic, they ultimately have to work together. Producing tethered educational initiatives that deliver trusted material to each audience, at the right health literacy level in an engaging setting, help us deliver on our commitment to improving patient outcomes.  We know from experience that to truly move the needle, you must engage and educate all parties,” Guild concluded.

ABOUT AIM AT MELANOMA FOUNDATION:  Melanoma is one of the fastest growing cancers in the United States and worldwide. It’s one of the most complex forms of cancer and has the most mutations of all solid cancers. Founded in 2004, AIM at Melanoma is the largest international melanoma foundation focused on the discovery of the cure for melanoma.  AIM’s global research initiatives include The International Melanoma Tissue Bank Consortium, The Melanoma International Collaboration for Adaptive Trials, and the International Melanoma Working Group.  AIM at Melanoma also provides education, connection to resources, and opportunities for meaningful engagement to help patients and caregivers/families better face the challenges of melanoma. For more information, visit www.AIMatMelanoma.org and follow our groundbreaking initiatives on Facebook, Twitter, and YouTube.

###

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.